everlinQ endoAVF Post Market Study

NCT02682420 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
100
Enrollment
INDUSTRY
Sponsor class

Stopped Company acquisition

Conditions

Interventions

Sponsor

C. R. Bard